SVP, Head of Preclinical Development & Translational Medicine
Dewpoint Therapeutics
Boston, Massachusetts
Dr. Lakshmi Amaravadi is currently SVP and Head of Preclinical & Translational Medicine function at Dewpoint Therapeutics. Her industry experience spans support of preclinical and clinical development of therapeutics across multiple disease areas including Neurology, Immunology/Inflammation, Oncology, Metabolic and Rare Diseases. Dr. Amaravadi is a recognized expert in the area of translational medicine strategies, biomarker development, PK and Immunogenicity assessments in support of drug candidates from late research phase through registration. Dr. Amaravadi has held several leadership positions in the American Association of Pharmaceutical Scientists, including serving as the Chair of scientific communities, member of scientific programming committees. She is currently serving on the leadership team of the Biomarkers & Precision Medicine community and an elected member of the AAPS Board. She has over 25 years of experience in Biopharm R&D and contributed to multiple drug approvals and authored several publications in peer reviewed journals. She received her Ph.D. in Molecular and Cell Biology at Indiana State University, followed by a post-doctoral fellowship at Walther Oncology Center, IU School of Medicine. Prior to joining Dewpoint her industry experience included positions at Millennium Pharmaceuticals, Biogen, Sanofi-Genzyme. and Shire Pharmaceuticals.
Disclosure information not submitted.
Tuesday, October 18, 2022
8:30 AM – 9:00 AM ET